References
1. Shapiro, A.J., et al., Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review. Pediatr Pulmonol, 2016.51 (2): p. 115-32.
2. Barber, A.T., et al., Use caution interpreting nasal nitric oxide: Overlap in primary ciliary dyskinesia and primary immunodeficiency. Pediatr Pulmonol, 2021.
3. Redding, G.J. and E.R. Carter, Chronic Suppurative Lung Disease in Children: Definition and Spectrum of Disease. Front Pediatr, 2017.5 : p. 30.
4. Shapiro, A.J., et al., Limitations of Nasal Nitric Oxide Testing in Primary Ciliary Dyskinesia. Am J Respir Crit Care Med, 2020.202 (3): p. 476-477.
5. Shapiro, A.J., et al., Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med, 2018. 197 (12): p. e24-e39.
6. Zysman-Colman, Z.N., et al., Nasal Nitric Oxide in Primary Immunodeficiency and Primary Ciliary Dyskinesia: Helping to Distinguish Between Clinically Similar Diseases. J Clin Immunol, 2019.39 (2): p. 216-224.